XML 27 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Non- Controlling Interest
Balances beginning ( in shares) at Dec. 31, 2021   585,878        
Balance beginning at Dec. 31, 2021 $ 592,923 $ 58 $ 1,568,638 $ 62 $ (983,941) $ 8,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   4,150        
Issuance of common stock upon exercise of stock options 10,176 $ 1 10,175     0
Issuance of common stock under Employee Stock Purchase Plan (in shares)   335        
Issuance of common stock under Employee Stock Purchase Plan 14,243   14,243      
Vesting of restricted stock units (in shares)   1,808        
Withholding taxes related to net share settlement of restricted stock units (in shares)   (3)        
Withholding taxes related to net share settlement of restricted stock units (150)   (150)      
Stock-based compensation expense 112,295   112,295      
Other (in shares)   28        
Other comprehensive income/(loss) (6)     (92)   86
Net loss (162,020)       (160,202) (1,818)
Balance ending (Shares) at Mar. 31, 2022   592,196        
Balance ending at Mar. 31, 2022 $ 567,461 $ 59 1,705,201 (30) (1,144,143) 6,374
Balances beginning ( in shares) at Dec. 31, 2022 604,674 604,674        
Balance beginning at Dec. 31, 2022 $ 305,035 $ 59 2,213,603 671 (1,908,307) (991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 2,263 2,263        
Issuance of common stock upon exercise of stock options $ 5,913 $ 1 5,912      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   639        
Issuance of common stock under Employee Stock Purchase Plan 19,921   19,921      
Vesting of restricted stock units (in shares)   2,911        
Stock-based compensation expense 184,904   184,904      
Other comprehensive income/(loss) (643)     (609)   (34)
Net loss $ (269,948)       (268,313) (1,635)
Balance ending (Shares) at Mar. 31, 2023 610,487 610,487        
Balance ending at Mar. 31, 2023 $ 245,182 $ 60 $ 2,424,340 $ 62 $ (2,176,620) $ (2,660)